Puma Biotechnology, Inc. (PBYI)

Puma Biotechnology Income Statement

Financials in millions USD. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Revenue	212	230.47	235.64	228.03	253.16	225.11
Revenue Growth (YoY)	-12.96%	-2.19%	3.34%	-9.92%	12.46%	-17.32%
Cost of Revenue	48.95	64.4	62.68	55.09	63.7	39.37
Gross Profit	163.04	166.06	172.96	172.94	189.45	185.74
Selling, General & Admin	69.09	80.16	89.31	89.98	116.29	118.49
Research & Development	60.4	54.94	50.38	52.24	71.87	97.65
Operating Expenses	129.49	135.1	139.69	142.22	188.16	216.14
Operating Income	33.56	30.97	33.27	30.72	1.29	-30.4
Interest Expense	-8.12	-12.45	-13.33	-11.59	-12.81	-14.05
Interest & Investment Income	4.33	4.72	2.61	0.81	0.16	0.49
Other Non Operating Income (Expenses)	1.15	0.86	0.76	-0.03	0.29	0.37
EBT Excluding Unusual Items	30.91	24.1	23.3	19.91	-11.07	-43.59
Asset Writedown	-	-	-0.63	-	-	-
Legal Settlements	-	-	-	-12.46	-9.59	-16.2
Other Unusual Items	-	-	-	-	-8.15	-
Pretax Income	30.91	24.1	22.67	0.46	-28.8	-59.79
Income Tax Expense	-6.07	-6.18	1.08	0.46	0.32	0.21
Net Income	36.98	30.28	21.59	0	-29.13	-60
Net Income to Common	36.98	30.28	21.59	0	-29.13	-60
Net Income Growth	59.11%	40.23%	1079450.00%	-	-	-
Shares Outstanding (Basic)	50	49	47	45	41	40
Shares Outstanding (Diluted)	50	49	48	45	41	40
Shares Change (YoY)	2.69%	3.26%	5.83%	10.56%	2.69%	2.08%
EPS (Basic)	0.74	0.62	0.46	0.00	-0.72	-1.52
EPS (Diluted)	0.74	0.62	0.45	0.00	-0.72	-1.52
EPS Growth	59.87%	37.78%	1022625.00%	-	-	-
Free Cash Flow	42.87	38.86	26.87	-15.83	20.65	0.73
Free Cash Flow Per Share	0.86	0.79	0.56	-0.35	0.51	0.02
Gross Margin	76.91%	72.06%	73.40%	75.84%	74.84%	82.51%
Operating Margin	15.83%	13.44%	14.12%	13.47%	0.51%	-13.51%
Profit Margin	17.44%	13.14%	9.16%	0.00%	-11.51%	-26.65%
Free Cash Flow Margin	20.22%	16.86%	11.40%	-6.94%	8.16%	0.32%
EBITDA	44.68	42.49	44.78	40.56	12.6	-20.37
EBITDA Margin	21.08%	18.44%	19.01%	17.79%	4.98%	-9.05%
D&A For EBITDA	11.12	11.52	11.52	9.84	11.31	10.03
EBIT	33.56	30.97	33.27	30.72	1.29	-30.4
EBIT Margin	15.83%	13.44%	14.12%	13.47%	0.51%	-13.51%
Effective Tax Rate	-	-	4.78%	99.56%	-	-
Revenue as Reported	212	230.47	235.64	228.03	253.16	225.11

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.

SEC Filings: 10-K · 10-Q